Search Results - "Mernagh, Paul"

Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison by Cherney, David, Folkerts, Kerstin, Mernagh, Paul, Nikodem, Mateusz, Pawlitschko, Joerg, Rossing, Peter, Hawkins, Neil

“…This study aimed to close an evidence gap concerning the relative efficacy of finerenone versus SGLT2is in patients with chronic kidney disease (CKD) and type…”
Get full text

Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7‐valent pneumococcal conjugate vaccine by Williams, Scott R, Mernagh, Paul J, Lee, Michael H T, Tan, Jonathan T

“…Objective: To evaluate trends in the incidence and serotype profile of invasive pneumococcal disease (IPD) in Australian children under 2 years of age after…”
Get full text

Cost-Effectiveness of Using Recombinant Human Thyroid-Stimulating Hormone before Radioiodine Ablation for Thyroid Cancer: The Canadian Perspective by Mernagh, Paul, MCom, Suebwongpat, Arsupol, MCom (Hons), Silverberg, Jay, MD, FRCPC, FACP, Weston, Adèle, PhD

“…ABSTRACT Objectives Radioiodine ablation for the treatment of thyroid cancer is traditionally performed after preparing patients by inducing hypothyroidism…”
Get full text

FC083: Finerenone and Canagliflozin in the Treatment of Chronic Kidney Disease and Type 2 Diabetes: Matching-Adjusted Indirect Treatment Comparison of Fidelio-DKD and Credence by Cherney, David, Folkerts, Kerstin, Mernagh, Paul, Nikodem, Mateusz, Pawlitschko, Joerg, Rossing, Peter

“…Abstract BACKGROUND AND AIMS Finerenone (FIN: an oral, nonsteroidal mineralocorticoid receptor antagonist) and canagliflozin (CAN: a sodium-glucose…”
Get full text

Cost-effectiveness of Finerenone in Addition to Standard of Care for Patients with Chronic Kidney Disease and Type 2 Diabetes in China by Ming, Jian, Hong, Guanqi, Xu, Yingrui, Mernagh, Paul, Pochopień, Michał, Li, Hongchao

“…Introduction Adding finerenone to current standard of care (SoC), as recommended by Chinese guidelines, has shown substantial benefit in delaying chronic…”
Get full text

MO375: The Health Economic Impact of Accurately Diagnosing CKD With and Without a UACR Test at Different Points in the Pathway of Disease Progression by Mernagh, Paul, Folkerts, Kerstin, Garreta Rufas, Antonio, Meredith, Kimberley, Harris, James, Wanner, Christoph, Rossing, Peter, Hobbs, Richard

“…Abstract BACKGROUND AND AIMS In the Kidney Disease Improving Global (KDIGO) guidelines, it is recommended that an accurate chronic kidney disease (CKD)…”
Get full text

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease by Folkerts, Kerstin, Millier, Aurelie, Smela, Beata, Olewinska, Elzbieta, Schmedt, Niklas, Mernagh, Paul, Kovesdy, Csaba P.

“…Background Mineralocorticoid receptor antagonists (MRAs) were shown to delay chronic kidney disease (CKD) progression in patients with hypertension and/or…”
Get full text

Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease by Cowie, Martin R, Lamy, André, Levy, Pierre, Mealing, Stuart, Millier, Aurélie, Mernagh, Paul, Cristeau, Olivier, Bowrin, Kevin, Briere, Jean-Baptiste

“…Abstract Aims In the COMPASS trial, rivaroxaban 2.5 mg twice daily (bid) plus acetylsalicylic acid (ASA) 100 mg once daily (od) performed better than ASA 100…”
Get full text

Targeted literature review of the burden of illness in patients with chronic kidney disease and type 2 diabetes by Fried, Linda F, Folkerts, Kerstin, Smeta, Beata, Bowrin, Kevin Deon, Mernagh, Paul, Millier, Aurelie, Kovesdy, Csaba P

“…Chronic kidney disease (CKD) is increasingly prevalent among patients with type 2 diabetes (T2D). CKD is associated with increased mortality rates, clinical…”
Get full text

Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes by Pochopień, Michał, Cherney, David Z I, Drzewiecka, Aleksandra, Folkerts, Kerstin, Levy, Pierre, Millier, Aurélie, Morris, Stephen, Palarczyk, Monika, Roy-Chaudhury, Prabir, Sullivan, Sean D, Mernagh, Paul

“…The FINE-CKD model was developed to estimate the cost-effectiveness of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). To…”
Get full text

FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes by Pochopień, Michał T, Cherney, David Z I, Folkerts, Kerstin, Levy, Pierre, Millier, Aurélie, Morris, Stephen, Roy-Chaudhury, Prabir, Sullivan, Sean D, Mernagh, Paul

“…Chronic kidney disease (CKD) is a progressive and irreversible disease often associated with type 2 diabetes (T2D). CKD is associated with an elevated risk of…”
Get full text

Lifetime cost effectiveness of a through-school nutrition and physical programme: Project Energize by Rush, Elaine, Obolonkin, Victor, McLennan, Stephanie, Graham, David, Harris, James D, Mernagh, Paul, Weston, Adèle R

“…Summary Project Energize, a multicomponent through-school physical activity and nutrition programme, is delivered to all primary school children in the Waikato…”
Get full text

Cost-Effectiveness of Single-Level Cervical Disc Arthroplasty by McCombe, Peter, MD, FRACS, Mernagh, Paul, Sears, William, MD, FRACS

Get full text

Using recombinant human thyroid-stimulating hormone for the diagnosis of recurrent thyroid cancer by Blamey, Stephen, Barraclough, Bruce, Delbridge, Leigh, Mernagh, Paul, Standfield, Lachlan, Weston, Adele

“…Background:  Recombinant human thyroid‐stimulating hormone (rhTSH) has been suggested as a diagnostic agent in the diagnosis of recurrent thyroid cancer,…”
Get full text